Addictive Potential: Unknown
Emergency Room Visits Yearly: Unknown
Mandatory Minimum Sentence: Unknown
Mechanism of Action: GABA(a) receptor agonist
Mebroqualone is also known as MBQ and 3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one. It is a sedative-hypnotic drug. It is also a designer quaalude, as it is an analog of mecloqualone and methaqualone. Mebroqualone was first created in the 1960’s. Yet, it wasn’t found in recreational drug distribution until 2013 (EMCDDA).
Side Effects and Adverse Reactions:
There is currently limited empirical data available on the side effects, adverse reactions, long term damage, and/or addiction potential of mebroqualone. In general, some of the side effects of quaaludes include:
- reduced heart rate
- reduced respiration
- dry mouth
- tingling sensations in the arms and legs
Remember, research chemicals are experimental chemicals that are not approved for human consumption. This is because not enough data exists currently about their effects in humans. Although some people are willing to ingest mebroqualone, it is unreasonable to assume that it is in any way safe to use recreationally.
- Synthesis and anticonvulsant evaluation of some novel 4 (3H)-quinazolinones
- Design, synthesis and anticonvulsant evaluation of novel 8-substituted-4 (3H)-quinazolines
- Detection and characterization of emerging psychoactive substances by ion mobility spectrometry
Other Informational Resources: